FDA approves traditional Chinese medicine

The Food and Drug Administration (FDA) has approved the use of a traditional Chinese medicine called Lianhua Qingwen. The capsule is used in China for coronavirus disease 2019 (COVID-19) patients with mild to moderate symptoms.

According to the Chinese Embassy, the medicine is also approved in other countries such as Brazil, Indonesia, and Canada. China hopes that the said medicine will help in eradicating the virus in the Philippines.

However, the FDA has pointed out that it has approved the medicine as a traditional medicine and not as a medicine for COVID-19 or other diseases. It is also approved as a prescription drug which means that a prescription from a doctor is required before taking it.

The FDA has reiterated that there is no approved COVID-19 cure or vaccine yet and has warned about buying products that are labelled as such. – Report from Sandra Samala

Popular

PBBM eyes more concrete measures to address effects of climate change

By Dean Aubrey Caratiquet As climate change makes its presence felt in various countries, especially the Philippines, President Ferdinand R. Marcos Jr. has shifted his...

PBBM to LGUs: Observe firm implementation of ‘no-build zones’ to address flooding woes

By Dean Aubrey Caratiquet As the enhanced southwest monsoon (habagat) continues to shed light on long-neglected matters, President Ferdinand R. Marcos Jr. made it clear...

PBBM vows stronger ties in meeting with Nigerian ambassador

By Dean Aubrey Caratiquet Expanding the scope of the Philippines’ international relations beyond its usual trading partners, President Ferdinand R. Marcos Jr. expressed his commitment...

PBBM to PCG flag officers: Uphold integrity in service of the Filipino people

By Dean Aubrey Caratiquet “Ang bawat paglalayag at bawat pagbabantay ay para sa sambayanang Pilipino.” This sentence best encapsulates the duty of Philippine Coast Guard (PCG)...